Cargando…

Associations of Cigarette Smoking and Polymorphisms in Brain-Derived Neurotrophic Factor and Catechol-O-Methyltransferase with Neurocognition in Alcohol Dependent Individuals during Early Abstinence

Chronic cigarette smoking and polymorphisms in brain-derived neurotrophic factor (BDNF) and catechol-O-methyltransferase (COMT) are associated with neurocognition in normal controls and those with various neuropsychiatric conditions. The influence of BDNF and COMT on neurocognition in alcohol depend...

Descripción completa

Detalles Bibliográficos
Autores principales: Durazzo, Timothy C., Hutchison, Kent E., Fryer, Susanna L., Mon, Anderson, Meyerhoff, Dieter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469037/
https://www.ncbi.nlm.nih.gov/pubmed/23087644
http://dx.doi.org/10.3389/fphar.2012.00178
_version_ 1782246029100318720
author Durazzo, Timothy C.
Hutchison, Kent E.
Fryer, Susanna L.
Mon, Anderson
Meyerhoff, Dieter J.
author_facet Durazzo, Timothy C.
Hutchison, Kent E.
Fryer, Susanna L.
Mon, Anderson
Meyerhoff, Dieter J.
author_sort Durazzo, Timothy C.
collection PubMed
description Chronic cigarette smoking and polymorphisms in brain-derived neurotrophic factor (BDNF) and catechol-O-methyltransferase (COMT) are associated with neurocognition in normal controls and those with various neuropsychiatric conditions. The influence of BDNF and COMT on neurocognition in alcohol dependence is unclear. The primary goal of this report was to investigate the associations of single nucleotide polymorphisms (SNPs) in BDNF Val66Met (rs6265) and COMT Val158Met (rs4680) with neurocognition in a treatment-seeking alcohol dependent cohort and determine if neurocognitive differences between non-smokers and smokers previously observed in this cohort persist when controlled for these functional SNPs. Genotyping was conducted on 70 primarily male treatment-seeking alcohol dependent participants (ALC) who completed a comprehensive neuropsychological battery after 33 ± 9 days of monitored abstinence. After controlling for COMT and BDNF genotypes, smoking ALC performed significantly worse than non-smoking ALC on the domains of auditory-verbal and visuospatial learning and memory, cognitive efficiency, general intelligence, processing speed, and global neurocognition. In smoking ALC, greater number of years of smoking over lifetime was related to poorer performance on multiple domains after controlling for genotypes and alcohol consumption. In addition, COMT Met homozygotes were superior to Val homozygotes on measures of executive skills and showed trends for higher general intelligence and visuospatial skills, while COMT Val/Met heterozygotes showed significantly better general intelligence than Val homozygotes. COMT Val homozygotes performed better than heterozygotes on auditory-verbal memory. BDNF genotype was not related to any neurocognitive domain. The findings are consistent with studies in normal controls and neuropsychiatric cohorts that reported COMT Met carriers demonstrated better performance on measures of executive skills and general intelligence. Results also indicated that the poorer performance of smoking compared to non-smoking ALC across multiple neurocognitive domains was not mediated by COMT or BDNF genotype. Overall, the findings lend support to the expanding clinical movement to make smoking cessation programs available to smokers at the inception of treatment for alcohol/substance use disorders.
format Online
Article
Text
id pubmed-3469037
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-34690372012-10-19 Associations of Cigarette Smoking and Polymorphisms in Brain-Derived Neurotrophic Factor and Catechol-O-Methyltransferase with Neurocognition in Alcohol Dependent Individuals during Early Abstinence Durazzo, Timothy C. Hutchison, Kent E. Fryer, Susanna L. Mon, Anderson Meyerhoff, Dieter J. Front Pharmacol Pharmacology Chronic cigarette smoking and polymorphisms in brain-derived neurotrophic factor (BDNF) and catechol-O-methyltransferase (COMT) are associated with neurocognition in normal controls and those with various neuropsychiatric conditions. The influence of BDNF and COMT on neurocognition in alcohol dependence is unclear. The primary goal of this report was to investigate the associations of single nucleotide polymorphisms (SNPs) in BDNF Val66Met (rs6265) and COMT Val158Met (rs4680) with neurocognition in a treatment-seeking alcohol dependent cohort and determine if neurocognitive differences between non-smokers and smokers previously observed in this cohort persist when controlled for these functional SNPs. Genotyping was conducted on 70 primarily male treatment-seeking alcohol dependent participants (ALC) who completed a comprehensive neuropsychological battery after 33 ± 9 days of monitored abstinence. After controlling for COMT and BDNF genotypes, smoking ALC performed significantly worse than non-smoking ALC on the domains of auditory-verbal and visuospatial learning and memory, cognitive efficiency, general intelligence, processing speed, and global neurocognition. In smoking ALC, greater number of years of smoking over lifetime was related to poorer performance on multiple domains after controlling for genotypes and alcohol consumption. In addition, COMT Met homozygotes were superior to Val homozygotes on measures of executive skills and showed trends for higher general intelligence and visuospatial skills, while COMT Val/Met heterozygotes showed significantly better general intelligence than Val homozygotes. COMT Val homozygotes performed better than heterozygotes on auditory-verbal memory. BDNF genotype was not related to any neurocognitive domain. The findings are consistent with studies in normal controls and neuropsychiatric cohorts that reported COMT Met carriers demonstrated better performance on measures of executive skills and general intelligence. Results also indicated that the poorer performance of smoking compared to non-smoking ALC across multiple neurocognitive domains was not mediated by COMT or BDNF genotype. Overall, the findings lend support to the expanding clinical movement to make smoking cessation programs available to smokers at the inception of treatment for alcohol/substance use disorders. Frontiers Media S.A. 2012-10-11 /pmc/articles/PMC3469037/ /pubmed/23087644 http://dx.doi.org/10.3389/fphar.2012.00178 Text en Copyright © 2012 Durazzo, Hutchison, Fryer, Mon and Meyerhoff. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Pharmacology
Durazzo, Timothy C.
Hutchison, Kent E.
Fryer, Susanna L.
Mon, Anderson
Meyerhoff, Dieter J.
Associations of Cigarette Smoking and Polymorphisms in Brain-Derived Neurotrophic Factor and Catechol-O-Methyltransferase with Neurocognition in Alcohol Dependent Individuals during Early Abstinence
title Associations of Cigarette Smoking and Polymorphisms in Brain-Derived Neurotrophic Factor and Catechol-O-Methyltransferase with Neurocognition in Alcohol Dependent Individuals during Early Abstinence
title_full Associations of Cigarette Smoking and Polymorphisms in Brain-Derived Neurotrophic Factor and Catechol-O-Methyltransferase with Neurocognition in Alcohol Dependent Individuals during Early Abstinence
title_fullStr Associations of Cigarette Smoking and Polymorphisms in Brain-Derived Neurotrophic Factor and Catechol-O-Methyltransferase with Neurocognition in Alcohol Dependent Individuals during Early Abstinence
title_full_unstemmed Associations of Cigarette Smoking and Polymorphisms in Brain-Derived Neurotrophic Factor and Catechol-O-Methyltransferase with Neurocognition in Alcohol Dependent Individuals during Early Abstinence
title_short Associations of Cigarette Smoking and Polymorphisms in Brain-Derived Neurotrophic Factor and Catechol-O-Methyltransferase with Neurocognition in Alcohol Dependent Individuals during Early Abstinence
title_sort associations of cigarette smoking and polymorphisms in brain-derived neurotrophic factor and catechol-o-methyltransferase with neurocognition in alcohol dependent individuals during early abstinence
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469037/
https://www.ncbi.nlm.nih.gov/pubmed/23087644
http://dx.doi.org/10.3389/fphar.2012.00178
work_keys_str_mv AT durazzotimothyc associationsofcigarettesmokingandpolymorphismsinbrainderivedneurotrophicfactorandcatecholomethyltransferasewithneurocognitioninalcoholdependentindividualsduringearlyabstinence
AT hutchisonkente associationsofcigarettesmokingandpolymorphismsinbrainderivedneurotrophicfactorandcatecholomethyltransferasewithneurocognitioninalcoholdependentindividualsduringearlyabstinence
AT fryersusannal associationsofcigarettesmokingandpolymorphismsinbrainderivedneurotrophicfactorandcatecholomethyltransferasewithneurocognitioninalcoholdependentindividualsduringearlyabstinence
AT monanderson associationsofcigarettesmokingandpolymorphismsinbrainderivedneurotrophicfactorandcatecholomethyltransferasewithneurocognitioninalcoholdependentindividualsduringearlyabstinence
AT meyerhoffdieterj associationsofcigarettesmokingandpolymorphismsinbrainderivedneurotrophicfactorandcatecholomethyltransferasewithneurocognitioninalcoholdependentindividualsduringearlyabstinence